Spark Therapeutics Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Spark Therapeutics in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Spark Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - | - | - | - |
| Ligand Pharmaceuticals | 1.580% | -4.082% | 7.429% | 106.593% | 13.253% | 168.571% | 75.210% |
| United Therapeutics | -1.290% | 1.185% | 1.662% | 76.802% | 15.937% | 151.090% | 205.802% |
| Ionis Pharmaceuticals Inc. | 0.710% | 0.404% | 0.717% | 113.629% | -4.974% | 97.311% | 109.064% |
News
Envista Q1 Earnings Call Highlights
Envista (NYSE:NVST) reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and
Six Flags Entertainment Q1 Earnings Call Highlights
Six Flags Entertainment (NYSE:FUN) reported improved first-quarter 2026 operating trends, with management pointing to higher attendance
The Quiet Retail Compounder Investors Keep Buying on Every Dip
Casey’s General Stores (NASDAQ: CASY) is a long-term retail holding that has tended to reward a buy-the-dip strategy. This company is as quality as they come, internally funding growth